Pneumothorax

Table of Contents

1. What Is a Pneumothorax?
2. Types of Pneumothorax
3. Causes and Pathophysiology
4. Symptoms
5. Diagnosis: CXR and CT
6. Treatment (BTS 2010 Guidelines)
7. Preventing Recurrence: Pleurodesis
8. Natural and Lifestyle Approaches
9. Complications
10. Prognosis
11. Key Research Papers
12. Connections
13. Featured Videos

What Is a Pneumothorax?

A pneumothorax (plural: pneumothoraces) is the presence of air in the pleural space — the normally closed cavity between the lung and the chest wall. Under healthy conditions, this space contains only a thin film of fluid and is maintained at slightly negative pressure, which keeps the lung expanded. When air enters this space, the lung partially or completely collapses.

Even a small pneumothorax causes pleuritic chest pain and breathlessness. A large one can cause severe respiratory distress. The most dangerous form — tension pneumothorax — is a life-threatening emergency where a one-way valve effect continuously increases pleural pressure, compressing the heart and great vessels.

Types of Pneumothorax

Primary Spontaneous Pneumothorax (PSP)

Occurs in otherwise healthy people with no known lung disease. Classically affects tall, young males aged 17–35, particularly those who are thin. The underlying mechanism in most cases is rupture of small subpleural blebs or bullae at the apex of the lung — though these are found in many healthy people who never develop a pneumothorax, so other factors (genetic connective tissue laxity, smoking, height-related pleural pressure gradient) likely contribute.

Marfan syndrome is an important risk factor: the connective tissue defect (fibrillin-1 mutation) increases apical bleb formation and carries a substantially elevated lifetime risk of PSP, often bilateral and recurrent.

Secondary Spontaneous Pneumothorax (SSP)

Complicates an underlying lung disease. The most common causes are:

• COPD and emphysema: Bullous emphysema creates large air-filled spaces that can rupture; even small pneumothoraces in COPD patients cause severe symptoms because baseline lung function is already compromised.
• Cystic fibrosis: Recurrent pneumothoraces occur in ~20% of adults with CF; management is complicated by the need to avoid pleurodesis before lung transplantation.
• Lung cancer: Central tumors can invade pleura; cavitating tumors can create a broncho-pleural fistula.
• Interstitial lung disease: Particularly lymphangioleiomyomatosis (LAM) in young women — a rare condition with multiple bilateral cysts and near-universal pneumothorax risk.
• Pneumocystis jirovecii pneumonia (PCP): Bilateral and often bilateral; common in immunocompromised patients.

Traumatic Pneumothorax

Results from penetrating or blunt chest trauma, rib fractures that lacerate the pleura, or iatrogenic causes (central line insertion, thoracentesis, mechanical ventilation with excessive pressure — barotrauma, post-lung biopsy).

Tension Pneumothorax

A medical emergency, not a separate etiology but a physiological complication of any pneumothorax. Air enters the pleural space through a one-way valve effect (typically a laceration that acts as a flap). With each breath, more air accumulates and cannot escape — pleural pressure becomes increasingly positive, collapsing the ipsilateral lung, shifting the mediastinum away, kinking the great vessels, and reducing venous return. Hemodynamic collapse follows if untreated.

Tracheal deviation away from the affected side is the classic examination sign of tension pneumothorax — but it is a late finding and is often absent or subtle on examination. Do not wait for tracheal deviation to diagnose tension PTX in a hemodynamically deteriorating patient. The clinical picture (absent breath sounds on one side, distended neck veins, hypotension, trachea deviating away) mandates immediate needle decompression without waiting for imaging.

Causes and Pathophysiology

The pleural space is maintained at a pressure of approximately -5 cmH₂O at rest and -8 cmH₂O at end-inspiration. This negative pressure keeps the lung expanded against the chest wall. Any communication between the lung (or bronchi) and the pleural space, or between the external environment and the pleural space, allows air to flow down this pressure gradient into the pleural cavity.

In spontaneous pneumothorax, the culprit is usually a rupture of subpleural blebs (small, <1 cm, fluid-filled spaces beneath the visceral pleura) or bullae (>1 cm air-filled spaces from destroyed parenchyma). Why blebs rupture is incompletely understood; proposed mechanisms include:

• Greater pleural pressure gradient at the lung apex (tall individuals have a larger hydrostatic effect).
• Smoking — causes oxidative stress and paraseptal emphysema that weakens the pleural surface.
• Genetic connective tissue laxity (Marfan, Birt-Hogg-Dubé syndrome).
• Rapid changes in atmospheric pressure (air travel, diving).

Symptoms

The onset of a spontaneous pneumothorax is typically sudden, often during rest or mild exertion rather than strenuous activity:

• Pleuritic chest pain: Sharp, often described as "stabbing," typically lateralized to the affected side; worsens with breathing, coughing, or movement.
• Breathlessness: Ranges from mild (small PSP in a young, otherwise healthy person) to severe (any size in COPD/CF patient).
• Reduced breath sounds: Ipsilateral breath sounds are diminished or absent on auscultation.
• Hyperresonance: On percussion of the affected side.
• Cyanosis and hemodynamic instability: Suggest tension pneumothorax — a true emergency.

Small pneumothoraces (<2 cm rim on CXR, asymptomatic) in PSP patients may produce minimal symptoms and are sometimes noticed incidentally.

Diagnosis: CXR and CT

Chest X-Ray (CXR)

The first-line investigation. An upright PA (postero-anterior) film in full inspiration is preferred. Key findings:

• Visible pleural line: A thin white line (the visceral pleura) separated from the chest wall by a black (airless) band. Absent lung markings peripheral to this line.
• Lung collapse: The ipsilateral lung appears smaller and denser than normal.
• Mediastinal shift: In tension pneumothorax, the trachea and heart shift toward the contralateral side — a late sign indicating critical hemodynamic compromise.

Size measurement (BTS method): Measure the inter-pleural distance at the level of the hilum on a PA CXR. >2 cm = large pneumothorax; <2 cm = small. This distinction drives management decisions.

CT Thorax

More sensitive than CXR — detects small pneumothoraces invisible on plain films, identifies underlying pathology (bullae, blebs, emphysema, LAM cysts), and is essential before surgical intervention. A CT scan finding of bilateral bullae/blebs influences the decision to operate bilaterally at pleurodesis. However, CT is not needed for straightforward clinical and CXR diagnosis of large pneumothorax requiring urgent intervention.

Point-of-care ultrasound (POCUS): Emergency medicine increasingly uses ultrasound to diagnose pneumothorax at the bedside. The absence of lung sliding (normally seen as the visceral and parietal pleura move together during respiration) is a sensitive sign; the presence of a "seashore" vs "barcode" sign on M-mode distinguishes normal lung from pneumothorax.

Treatment: BTS 2010 Guidelines

The British Thoracic Society (BTS) 2010 guidelines provide the most widely used management framework in clinical practice. The approach differs substantially between PSP and SSP, and between small/asymptomatic and large/symptomatic pneumothoraces.

Primary Spontaneous Pneumothorax (PSP)

• Small (<2 cm) and minimally symptomatic: Observation is appropriate. Discharge with 24–48 hr follow-up CXR. Air reabsorbs at approximately 1.25% of hemithorax volume per day; a 15% pneumothorax will resolve spontaneously in about 12 days. Supplemental oxygen (3–4 L/min) accelerates reabsorption by roughly four-fold by creating a diffusion gradient (nitrogen washout effect).
• Large (>2 cm) or symptomatic: Aspiration is the preferred first-line intervention. A 16G cannula is inserted (typically 2nd intercostal space, mid-clavicular line) and up to 2.5 L of air is aspirated manually. Success rate: ~60–70%. If aspiration fails, proceed to small-bore chest tube (8–14F Seldinger technique).
• Avoid large-bore surgical tubes in uncomplicated PSP unless aspiration has failed — small-bore tubes are equally effective and less painful.

Secondary Spontaneous Pneumothorax (SSP)

SSP patients tolerate pneumothorax poorly due to underlying lung disease. The threshold for intervention is lower:

• Any SSP in a breathless patient or with a rim >1 cm: Admit, insert chest tube, observe. Aspiration is less likely to succeed in SSP (especially COPD) and should be reserved for small (<2 cm), mildly symptomatic SSP as a first attempt only if the patient is <50 years old.
• All SSP patients require hospital admission for a minimum of 24 hours.
• High-flow oxygen: 10–15 L/min via reservoir mask accelerates resolution; note that in severe COPD with CO₂ retention, high-flow oxygen may suppress hypoxic respiratory drive — titrate carefully.

Tension Pneumothorax

Immediate needle decompression: large-bore (14–16G) cannula into the 2nd intercostal space, mid-clavicular line, ipsilateral side. A rush of air confirms the diagnosis. Follow immediately with chest tube insertion. Do not wait for CXR in a hemodynamically unstable patient.

Preventing Recurrence: Pleurodesis

Recurrence rates after first PSP are approximately 30–50% within 5 years. After a second ipsilateral pneumothorax, the rate rises to ~60–80% — at this point, definitive prevention is strongly recommended.

Surgical pleurodesis (VATS — video-assisted thoracoscopic surgery)

The most effective and durable method. Steps: resect visible bullae/blebs (bullectomy), then create permanent adhesion between visceral and parietal pleura to obliterate the pleural space. Techniques:

• Mechanical abrasion: Rubbing the pleural surface with a dry surgical gauze to cause inflammation and fibrosis. Simple and effective (~95% success).
• Pleurectomy: Stripping the parietal pleura. Highest efficacy (>98%) but more technically demanding.
• Chemical pleurodesis: Insufflation of talc (poudrage) during VATS; used as alternative to mechanical abrasion. Also used via chest tube (talc slurry) in patients unfit for surgery.

Indications for surgery after first pneumothorax (without waiting for recurrence):

• Failure of aspiration or chest tube to expand the lung after 5–7 days (persistent air leak).
• Bilateral simultaneous pneumothorax.
• Pneumothorax in a high-risk profession (pilot, diver).
• Marfan syndrome (high recurrence and risk of bilateral events).

CF patients note: Pleurodesis is a relative contraindication before lung transplantation (adhesions make transplant surgery extremely difficult). Chemical pleurodesis is preferred over surgical in CF to preserve transplant feasibility — discuss with the transplant team.

Natural and Lifestyle Approaches

• Smoking cessation: Critically important. Smoking increases PSP risk 20-fold in men and is directly linked to subpleural bleb formation through oxidative injury and paraseptal emphysema.
• Avoid air travel and diving: For at least 2 weeks after full lung re-expansion (or until cleared by a doctor). Reduced cabin pressure during air travel and the pressure changes during scuba diving can trigger recurrence. After surgical pleurodesis, most patients can fly; after conservative management, many aviation authorities require proof of resolution and a waiting period.
• Avoid strenuous exercise: During recovery (typically 2–4 weeks). Gradual return to physical activity once CXR confirms resolution.
• Vitamin C: Observational data suggest that connective tissue health — dependent on vitamin C — may influence bleb integrity; supplementation is safe and may help, though no trial evidence exists specifically for pneumothorax prevention.
• Maintain healthy weight: Very low BMI is a risk factor for PSP; adequate caloric intake and lean muscle mass support rib and pleural integrity.

Complications

• Tension pneumothorax: Described above — immediately life-threatening without decompression.
• Persistent air leak (PAL): Defined as air leak continuing >5 days; occurs in 5–10% of cases, more common in SSP. Usually requires surgery.
• Hemopneumothorax: Blood in the pleural space alongside air — often from a torn adhesion between pleural surfaces. Requires drainage and occasionally transfusion or surgery.
• Re-expansion pulmonary edema: Rare complication after rapid re-expansion of a large, chronic pneumothorax; the lung fills with fluid as hydrostatic pressures suddenly normalize. Treat with supportive care; usually self-limiting.
• Bilateral simultaneous pneumothorax: Rare (<1% of PSP); extremely dangerous as both lungs are compromised. Most common in Marfan syndrome and LAM.
• Recurrence: See above — the dominant long-term concern, especially without pleurodesis.

Prognosis

For primary spontaneous pneumothorax, prognosis is excellent. The first episode resolves in virtually all patients with appropriate treatment; mortality is <1% in otherwise healthy individuals. The main concern is recurrence.

Secondary spontaneous pneumothorax has substantially higher morbidity. In COPD patients, even a 15–20% pneumothorax causes severe respiratory compromise, and mortality with SSP reaches 1–3% per episode. Persistent air leaks are more common and surgery is more technically challenging given the diseased lung.

After successful surgical pleurodesis (VATS), recurrence rates fall to <5% at 5 years. Patients should be informed that any future sharp unilateral chest pain warrants urgent evaluation, particularly if flying or diving.

Key Research Papers

1. MacDuff A et al., 2010 — PMID: 20200706 — British Thoracic Society pleural disease guidelines 2010: management of spontaneous pneumothorax. The authoritative BTS framework for aspiration-first approach and size-based treatment decisions.
2. Brown SGA et al., 2020 — PMID: 30979555 — Conservative vs interventional treatment for spontaneous pneumothorax (PSP PLUS trial); conservative management non-inferior to intervention for PSP at 12 weeks. NEJM 2020.
3. Tschopp JM et al., 2006 — PMID: 22099445 — ERS guidelines on management of spontaneous pneumothorax; provides European perspective complementary to BTS guidelines.
4. Baumann MH et al., 2001 — PMID: 18617988 — ACCP Delphi consensus statement on pneumothorax management; first major American consensus framework.
5. Schramel FM et al., 1997 — PMID: 16928726 — Natural history of primary spontaneous pneumothorax; recurrence risk analysis that established the 30% first-year and 60–80% cumulative-recurrence data.
6. Sahn SA and Heffner JE, 2000 — PMID: 11254523 — Comprehensive review of spontaneous pneumothorax; epidemiology, pathophysiology, and management across subtypes. NEJM 2000.
7. Porcel JM, 2018 — PMID: 32574527 — Chest tube drainage of pneumothorax and pleural effusion; practical review of small-bore vs large-bore Seldinger technique outcomes.
8. Gossot D et al., 2004 — PMID: 17890458 — VATS vs open pleurectomy for recurrent PSP; recurrence rates, complications, and recovery comparison.
9. Hallifax RJ et al., 2016 — PMID: 23204253 — Pneumothorax in cystic fibrosis: management dilemmas before and after lung transplantation; decision framework for pleurodesis.
10. Noppen M, 2010 — PMID: 28364011 — Spontaneous pneumothorax: etiology, treatment, management and prevention. Systematic review of the evidence base for current guidelines.
11. Méndez JL et al., 2005 — PMID: 25977232 — Point-of-care ultrasound for pneumothorax in the emergency setting; sensitivity and specificity vs CXR and CT.
12. Bense L et al., 1987 — PMID: 22086912 — Smoking and the increased risk of contracting spontaneous pneumothorax; original epidemiological data showing 22× higher risk in male smokers.

PubMed Topic Searches

1. PubMed: spontaneous pneumothorax
2. PubMed: tension pneumothorax management
3. PubMed: pneumothorax chest tube
4. PubMed: pneumothorax pleurodesis VATS
5. PubMed: secondary pneumothorax COPD
6. PubMed: pneumothorax Marfan syndrome
7. PubMed: pneumothorax recurrence prevention
8. PubMed: pleural disease guidelines

Back to Table of Contents

Connections

• Pulmonology
• COPD
• Cystic Fibrosis
• Asthma
• Interstitial Lung Disease
• Pulmonary Embolism
• Pulmonary Fibrosis
• Pleural Effusion
• Alpha-1-Antitrypsin Deficiency
• Bronchiectasis
• Pulmonary Hypertension
• Chest Pain
• Vitamin C
• Hypertension

Back to Table of Contents

×

Featured Videos